NAGE Rasio cepet ChromaDex Corp

Chromadex Corp (NAGE) creates unique Niagen dietary supplements, utilizing a D2C model and robust patent protection to maximize profits. The stock price trend with the 5.35 indicator clearly demonstrates the asset's dynamics. The business relies on third-party contractors for production and logistics, while strong intellectual capital in cellular metabolism reliably shields the company from competitor dumping.

Due to patent control over Niagen production, Chromadex Corp (NAGE) maintains high margins, which directly impacts the volume of available capital. The current 5.35 value for the quick ratio reflects the company's ability to settle short-term obligations using only cash and accounts receivable, excluding inventory. This chart allows investors to assess the business's real solvency without relying on the liquidation of stock.